Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study | 最新消息 - 中國醫藥大學附設醫院

:::

院外單位健康通報

實名登記系統

"> 回首頁LOGO按鈕

繁簡 EN

最新消息

News & Message

:::

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

最新消息

2026/2/3

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: The Phase III, Randomized LEAP-015 Study

回上頁

相關文章

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer

Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer

Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer

Trastuzumab Deruxtecan or Ramucirumab plus Paclitaxel in Gastric Cancer

$INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer$

INTEGRATE IIa Phase III Study: Regorafenib for Refractory Advanced Gastric Cancer

側邊開關圖示

中國醫點通

百度搜狗 360搜索中方与欧盟、东盟讨论应对美国“对等关税” 安切洛蒂是该离开皇马了吗？美反华政客内讧了挪威男人的家庭地位似乎不高啊全部滚出美国？特朗普作出决定，不再援助一分钱，俄媒：干得漂亮

<code id='e6a4d'></code><style id='0fb37'></style>

<acronym id='33ef0'></acronym>

<center id='f52fb'><center id='dc136'><tfoot id='26782'></tfoot></center><abbr id='54c29'><dir id='8b0d6'><tfoot id='f0730'></tfoot><noframes id='524d9'>

<optgroup id='e3ce4'><strike id='423f1'><sup id='9c820'></sup></strike><code id='4c5ea'></code></optgroup>

<b id='7c930'><label id='894a0'><select id='0c8ca'><dt id='4339a'><span id='9f864'></span></dt></select></label></b><u id='f9bb8'></u>

~~<i id='ae4e3'><strike id='f31b5'><tt id='e90b7'><pre id='a7fa5'></pre></tt></strike></i>~~